198 related articles for article (PubMed ID: 32597184)
1. Development of Conformationally Constrained α-RgIA Analogues as Stable Peptide Antagonists of Human α9α10 Nicotinic Acetylcholine Receptors.
Zheng N; Christensen SB; Blakely A; Dowell C; Purushottam L; McIntosh JM; Chou DH
J Med Chem; 2020 Aug; 63(15):8380-8387. PubMed ID: 32597184
[TBL] [Abstract][Full Text] [Related]
2. From Crystal Structures of RgIA4 in Complex with
Pan S; Fan Y; Zhu X; Xue Y; Luo S; Wang X
Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940708
[TBL] [Abstract][Full Text] [Related]
3. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
Ellison M; Feng ZP; Park AJ; Zhang X; Olivera BM; McIntosh JM; Norton RS
J Mol Biol; 2008 Apr; 377(4):1216-27. PubMed ID: 18295795
[TBL] [Abstract][Full Text] [Related]
4. Molecular Determinants Conferring the Stoichiometric-Dependent Activity of α-Conotoxins at the Human α9α10 Nicotinic Acetylcholine Receptor Subtype.
Yu R; Tae HS; Tabassum N; Shi J; Jiang T; Adams DJ
J Med Chem; 2018 May; 61(10):4628-4634. PubMed ID: 29733583
[TBL] [Abstract][Full Text] [Related]
5. Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
Halai R; Clark RJ; Nevin ST; Jensen JE; Adams DJ; Craik DJ
J Biol Chem; 2009 Jul; 284(30):20275-84. PubMed ID: 19447885
[TBL] [Abstract][Full Text] [Related]
6. Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models.
Kryukova EV; Ivanov IA; Lebedev DS; Spirova EN; Egorova NS; Zouridakis M; Kasheverov IE; Tzartos SJ; Tsetlin VI
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30469507
[TBL] [Abstract][Full Text] [Related]
7. Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors.
Huynh PN; Harvey PJ; Gajewiak J; Craik DJ; Michael McIntosh J
Biochem Pharmacol; 2020 Nov; 181():114124. PubMed ID: 32593612
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies on alpha-conotoxins.
Muttenthaler M; Akondi KB; Alewood PF
Curr Pharm Des; 2011 Dec; 17(38):4226-41. PubMed ID: 22204424
[TBL] [Abstract][Full Text] [Related]
9. Globular and ribbon isomers of Conus geographus α-conotoxins antagonize human nicotinic acetylcholine receptors.
Tae HS; Gao B; Jin AH; Alewood PF; Adams DJ
Biochem Pharmacol; 2021 Aug; 190():114638. PubMed ID: 34062129
[TBL] [Abstract][Full Text] [Related]
10. Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism.
Gajewiak J; Christensen SB; Dowell C; Hararah F; Fisher F; Huynh PN; Olivera BM; McIntosh JM
J Med Chem; 2021 Jul; 64(13):9271-9278. PubMed ID: 34142837
[TBL] [Abstract][Full Text] [Related]
11. Effects of cyclization on stability, structure, and activity of α-conotoxin RgIA at the α9α10 nicotinic acetylcholine receptor and GABA(B) receptor.
Halai R; Callaghan B; Daly NL; Clark RJ; Adams DJ; Craik DJ
J Med Chem; 2011 Oct; 54(19):6984-92. PubMed ID: 21888386
[TBL] [Abstract][Full Text] [Related]
12. d-Amino Acid Substitution of α-Conotoxin RgIA Identifies its Critical Residues and Improves the Enzymatic Stability.
Ren J; Zhu X; Xu P; Li R; Fu Y; Dong S; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30823399
[TBL] [Abstract][Full Text] [Related]
13. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
[TBL] [Abstract][Full Text] [Related]
14.
Margiotta F; Micheli L; Ciampi C; Ghelardini C; McIntosh JM; Di Cesare Mannelli L
Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547920
[No Abstract] [Full Text] [Related]
15. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
[TBL] [Abstract][Full Text] [Related]
16. α-Conotoxin Bt1.8 from Conus betulinus selectively inhibits α6/α3β2β3 and α3β2 nicotinic acetylcholine receptor subtypes.
Ning H; Huang B; Tae HS; Liu Z; Yu S; Li L; Zhang L; Adams DJ; Guo C; Dai Q
J Neurochem; 2021 Oct; 159(1):90-100. PubMed ID: 34008858
[TBL] [Abstract][Full Text] [Related]
17. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.
Cuny H; Kompella SN; Tae HS; Yu R; Adams DJ
J Biol Chem; 2016 Nov; 291(45):23779-23792. PubMed ID: 27646000
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain.
Zheng N; Christensen SB; Dowell C; Purushottam L; Skalicky JJ; McIntosh JM; Chou DH
J Med Chem; 2021 Jul; 64(13):9513-9524. PubMed ID: 34161094
[TBL] [Abstract][Full Text] [Related]
19. A novel inhibitor of α9α10 nicotinic acetylcholine receptors from Conus vexillum delineates a new conotoxin superfamily.
Luo S; Christensen S; Zhangsun D; Wu Y; Hu Y; Zhu X; Chhabra S; Norton RS; McIntosh JM
PLoS One; 2013; 8(1):e54648. PubMed ID: 23382933
[TBL] [Abstract][Full Text] [Related]
20. Neuronal Nicotinic Acetylcholine Receptor Modulators from Cone Snails.
Abraham N; Lewis RJ
Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29899286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]